Go Pro

Greenwich LifeSciences (GLSI) Earnings Date, Estimates & Call Transcripts

Greenwich LifeSciences logo
$16.92 +1.37 (+8.81%)
As of 08/12/2026 04:00 PM Eastern

Greenwich LifeSciences Earnings Summary

Greenwich LifeSciences released Q2 2026 earnings on August 11, 2026, reporting an EPS of -$0.27, which beat the consensus estimate of -$0.33 by $0.06. With a trailing EPS of -$1.57, Greenwich LifeSciences' earnings are expected to grow next year, from ($1.38) to ($1.17) per share.

Latest Q2
Earnings Date
Aug. 11Estimated
Consensus EPS
(Aug. 11)
-$0.33
Actual EPS
(Aug. 11)
-$0.27 Beat By $0.06
Get Greenwich LifeSciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Greenwich LifeSciences and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

GLSI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Greenwich LifeSciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.35-$0.31-$0.33
Q2 20262-$0.36-$0.30-$0.33
Q3 20262-$0.37-$0.30-$0.34
Q4 20262-$0.40-$0.30-$0.35
FY 2026 8 -$1.48 -$1.21 -$1.35
Q1 20271-$0.30-$0.30-$0.30
Q2 20271-$0.29-$0.29-$0.29
Q3 20271-$0.29-$0.29-$0.29
Q4 20271-$0.29-$0.29-$0.29

Greenwich LifeSciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026-$0.33-$0.27+$0.06-$0.27--
11/14/2025Q3 2025-$0.30-$0.30--$0.30--
8/14/2025Q2 2025-$0.24-$0.30 -$0.06-$0.30--
5/20/2025Q1 2025-$0.24-$0.25 -$0.01-$0.25--
4/15/2025Q4 2024-$0.21-$0.61 -$0.40-$0.61--
8/14/2024--$0.20-$0.20--$0.20--

Greenwich LifeSciences Earnings - Frequently Asked Questions

Greenwich LifeSciences (NASDAQ:GLSI) last announced its quarterly earning data on Tuesday, August 11, 2026. Learn more on GLSI's earnings history.

In the previous quarter, Greenwich LifeSciences (NASDAQ:GLSI) reported ($0.27) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.33) by $0.06. Learn more on analysts' earnings estimate vs. GLSI's actual earnings.

Greenwich LifeSciences (NASDAQ:GLSI) has a recorded net income of -$19.36 million. GLSI has generated -$1.57 earnings per share over the last four quarters.

Greenwich LifeSciences' earnings are expected to grow from ($1.38) per share to ($1.17) per share in the next year.


Earnings data for NASDAQ:GLSI is sourced from Fiscal.ai, with the most recent quarter reported on 8/11/2026. New results are added as companies report their earnings.
From Our Partners